Brentuximab Vedotin Biosimilar - Research Grade

Product Specifications

Background

Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.

Product Name Alternative

MMAE

Host

CHO Cells

Reactivity

Human

Target

TNFRSF8 / CD30

Isotype

IgG1

Applications

Functional Assays

Concentration

1mg/mL

Purity

>90% by SDS-PAGE

Shipping Conditions

Room Temp

Storage Conditions

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Formulation

25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

Applications Notes

Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP1-19139V 0.1 mL

Rabbit Polyclonal SDE2 Antibody [DyLight 405]

View Details

JOT-AP11343-01 50ul

MMP9 (Cleaved-Met94) Rabbit Polyclonal Antibody

View Details

JOT-AP11343-02 100ul

MMP9 (Cleaved-Met94) Rabbit Polyclonal Antibody

View Details

168861-AF-AP 100 µL

SUMO-1 (GAP-modifying protein 1, GMP1, OFC10, PIC1, SENP2, Sentrin 1, Small ubiquitin-related modifier 1, SMT3, SMT3 suppressor of mif two 3 homolog 1, SMT3C, SMT3H3, Ubiquitin homology domain protein PIC1, Ubiquitin Like 1, Ubiquitin like protein UBL1) (AP) discontinued

View Details

45321121 3x 1.0µg DNA

SPIN2A CRISPRa sgRNA lentivector (set of three targets)(Human)

View Details

MBS1240679-01 0.02 mg (E-Coli)

Recombinant Aeromonas salmonicida LexA repressor (lexA)

View Details